Try our beta test site
92 studies found for:    avid
Show Display Options
Rank Status Study
1 Enrolling by invitation Randomized Trial of a Social Networks Intervention
Condition: Adolescent Behavior
Intervention: Other: AVID Intervention
2 Recruiting MIBG Therapy for Patients With MIBG Avid Tumors
Condition: MIBG Avid Tumors
Intervention: Drug: MIBG
3 Completed Clinical Study of Asahi ViE Dialyzer in Canada
Condition: Kidney Failure, Chronic
Intervention: Device: ViE-21
4 Withdrawn The Effects of Active VItamin D on Left Atrial Volume Index
Condition: Heart Failure
Intervention: Drug: Paricalcitol
5 Unknown  11C-Acetate PET/CT Non-FDG-Avid Tumors
Conditions: Soft Tissue Sarcomas;   Thyroid Cancer;   Lung Cancer;   Indolent Lymphoma;   Neuroendocrine Tumors;   GIST;   Uterine Malignancies;   Carcinoma, Hepatocellular;   Carcinoma, Lobular;   Teratoma
6 Completed Augmenting 18F-AV-1451 Dosimetry Estimates
Condition: Alzheimer's Disease
Intervention: Drug: 18F-AV-1451
7 Recruiting Clinical Evaluation of Florbetapir F 18 (18F-AV-45)
Conditions: Alzheimer Disease;   Mild Cognitive Impairment;   Neurodegenerative Diseases
Intervention: Drug: Florbetapir F 18
8 Not yet recruiting Flortaucipir 18F PET Imaging in BIOCARD Study
Condition: Cognitive Decline
Intervention: Drug: 18F-AV-1451
9 Not yet recruiting Flortaucipir PET Imaging in Subjects With FTD
Condition: Frontotemporal Dementia
Interventions: Drug: 18F-AV-1451;   Drug: 18F-AV-45
10 Recruiting 18F-AV-1451 Autopsy Study
Condition: Alzheimer's Disease
Intervention: Drug: 18F-AV-1451
11 Completed Antiarrhythmics Versus Implantable Defibrillators (AVID)
Conditions: Arrhythmia;   Cardiovascular Diseases;   Death, Sudden, Cardiac;   Heart Diseases;   Tachycardia, Ventricular;   Ventricular Fibrillation
Interventions: Device: defibrillators, implantable;   Drug: amiodarone amiodarone;   Drug: sotalol
12 Recruiting Iodine I-131 With or Without Selumetinib in Treating Patients With Recurrent or Metastatic Thyroid Cancer
Conditions: Poorly Differentiated Thyroid Gland Carcinoma;   Recurrent Thyroid Gland Carcinoma;   Stage IVA Thyroid Gland Follicular Carcinoma;   Stage IVA Thyroid Gland Papillary Carcinoma;   Stage IVB Thyroid Gland Follicular Carcinoma;   Stage IVB Thyroid Gland Papillary Carcinoma;   Stage IVC Thyroid Gland Follicular Carcinoma;   Stage IVC Thyroid Gland Papillary Carcinoma
Interventions: Radiation: Iodine I-131;   Other: Laboratory Biomarker Analysis;   Other: Placebo;   Drug: Selumetinib
13 Completed Exercise in Asymptomatic Pre-Alzheimer's Disease Pilot Study
Condition: Alzheimer's Disease Prevention
Intervention: Behavioral: Aerobic vs. Non-Aerobic exercise
14 Completed
Has Results
Evaluation of Reader Training Processes
Condition: Alzheimer's Disease
Intervention: Drug: florbetapir F 18
15 Completed
Has Results
Imaging Characteristics of Florbetapir 18F in Patients With Frontotemporal Dementia, Alzheimer's Disease and Normal Controls.
Conditions: Alzheimer's Disease;   Frontotemporal Dementia
Interventions: Drug: florbetapir 18F;   Drug: 18F-FDG
16 Terminated A Phase 0, Open Label, Multi-center Exploratory and Safety Study of [F-18]T807
Conditions: Alzheimers Disease;   AD
Intervention: Radiation: [F18] T807
17 Terminated A Phase 0, Open Label, Multi-Center, Exploratory and Safety Study of [F-18]T808
Condition: Alzheimers Disease
Intervention: Radiation: [F18] T808
18 Completed Quantitative 18F-AV-133 PET Imaging in Subjects With Diabetes and Healthy Controls
Condition: Type 2 Diabetes
Interventions: Drug: 18F-AV-133;   Drug: 10% Arginine Hydrochloride-R-Gene 10
19 Completed
Has Results
Effectiveness of Florbetapir (18F) PET Imaging in Changing Patient Management and the Relationship Between Scan Status and Cognitive Decline
Condition: Alzheimer's Disease
Intervention: Drug: florbetapir (18F)
20 Completed
Has Results
A Phase II Trial of Florbetapir (18F) Positron Emission Tomography (PET) Imaging in Japan of Healthy Volunteers, Patients With Mild Cognitive Impairment (MCI) and Patients With Alzheimer's Disease (AD)
Conditions: Alzheimer's Disease;   Mild Cognitive Impairment
Intervention: Drug: florbetapir (18F)

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.